메뉴 건너뛰기




Volumn 6, Issue 1-2, 2006, Pages 27-35

Neoadjuvant chemotherapy for ovarian cancer: Pro versus con

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; PACLITAXEL; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

EID: 34548565905     PISSN: 14733404     EISSN: 14733412     Source Type: Journal    
DOI: 10.1080/14733400600743295     Document Type: Review
Times cited : (1)

References (55)
  • 1
    • 33645526144 scopus 로고    scopus 로고
    • Cancer statistics, 2006
    • Jemal, A., Siegel, R. and Ward, E. (2006) Cancer statistics, 2006. CA Cancer J Clin, 56:2, pp. 106-130.
    • (2006) CA Cancer J Clin , vol.56 , Issue.2 , pp. 106-130
    • Jemal, A.1    Siegel, R.2    Ward, E.3
  • 3
    • 0028801693 scopus 로고
    • Ovarian cancer
    • NIH consensus conference NIH Consensus Development Panel on Ovarian Cancer. JAMA
    • NIH consensus conference (1995) Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA, 273:6, pp. 491-497.
    • (1995) Screening, Treatment, and Follow-up , vol.273 , Issue.6 , pp. 491-497
  • 5
    • 0016586897 scopus 로고
    • Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
    • Griffiths, C. T. (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr, 42, pp. 101-104.
    • (1975) Natl Cancer Inst Monogr , vol.42 , pp. 101-104
    • Griffiths, C.T.1
  • 6
    • 0346423733 scopus 로고    scopus 로고
    • Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
    • Alberts, D. S., Liu, P. Y. and Hannigan, E. V. (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med, 335:26, pp. 1950-1955.
    • (1996) N Engl J Med , vol.335 , Issue.26 , pp. 1950-1955
    • Alberts, D.S.1    Liu, P.Y.2    Hannigan, E.V.3
  • 7
    • 0031281766 scopus 로고    scopus 로고
    • Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?
    • Krepart, G. V. and Lotocki, R. J. (1997) Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?. Gynecol Oncol, 67:2, pp. 208-214.
    • (1997) Gynecol Oncol , vol.67 , Issue.2 , pp. 208-214
    • Krepart, G.V.1    Lotocki, R.J.2
  • 8
    • 0032077205 scopus 로고    scopus 로고
    • Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
    • Eisenkop, S. M., Friedman, R. L. and Wang, H. J. (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol, 69:2, pp. 103-108.
    • (1998) Gynecol Oncol , vol.69 , Issue.2 , pp. 103-108
    • Eisenkop, S.M.1    Friedman, R.L.2    Wang, H.J.3
  • 9
    • 0020460589 scopus 로고
    • Clinical cancer research: An embattled species
    • Frei 3rd, E. (1982) Clinical cancer research: An embattled species. Cancer, 50:10, pp. 1979-1992.
    • (1982) Cancer , vol.50 , Issue.10 , pp. 1979-1992
    • Frei III, E.1
  • 10
    • 0029737381 scopus 로고    scopus 로고
    • A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
    • Walsh, T. N., Noonan, N. and Hollywood, D. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med, 335:7, pp. 462-467.
    • (1996) N Engl J Med , vol.335 , Issue.7 , pp. 462-467
    • Walsh, T.N.1    Noonan, N.2    Hollywood, D.3
  • 11
    • 0033776349 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): Improved treatment for gastric adenocarcinoma
    • Weese, J. L., Harbison, S. P. and Stiller, G. D. (2000) Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): Improved treatment for gastric adenocarcinoma. Surgery, 128:4, pp. 564-571.
    • (2000) Surgery , vol.128 , Issue.4 , pp. 564-571
    • Weese, J.L.1    Harbison, S.P.2    Stiller, G.D.3
  • 12
    • 0028898526 scopus 로고
    • Interval debulking of ovarian cancer-an interim measure
    • Berek, J. S. (1995) Interval debulking of ovarian cancer-an interim measure. N Engl J Med, 332:10, pp. 675-677.
    • (1995) N Engl J Med , vol.332 , Issue.10 , pp. 675-677
    • Berek, J.S.1
  • 13
    • 0020681712 scopus 로고
    • Primary cytoreductive surgery for epithelial ovarian cancer
    • Hacker, N. F., Berek, J. S. and Lagasse, L. D. (1983) Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol, 61:4, pp. 413-420.
    • (1983) Obstet Gynecol , vol.61 , Issue.4 , pp. 413-420
    • Hacker, N.F.1    Berek, J.S.2    Lagasse, L.D.3
  • 14
    • 0026620239 scopus 로고
    • The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
    • Hoskins, W. J., Bundy, B. N. and Thigpen, J. T. (1992) The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study. Gynecol Oncol, 47:2, pp. 159-166.
    • (1992) Gynecol Oncol , vol.47 , Issue.2 , pp. 159-166
    • Hoskins, W.J.1    Bundy, B.N.2    Thigpen, J.T.3
  • 15
    • 0033812797 scopus 로고    scopus 로고
    • A critique of surgical cytoreduction in advanced ovarian cancer
    • Covens, A. L. (2000) A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol, 78:3, pp. 269-274.
    • (2000) Gynecol Oncol , vol.78 , Issue.3 , pp. 269-274
    • Covens, A.L.1
  • 16
    • 0026546910 scopus 로고
    • Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis?
    • Hunter, R. W., Alexander, N. D. and Soutter, W. P. (1992) Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis?. Am J Obstet Gynecol, 166:2, pp. 504-511.
    • (1992) Am J Obstet Gynecol , vol.166 , Issue.2 , pp. 504-511
    • Hunter, R.W.1    Alexander, N.D.2    Soutter, W.P.3
  • 17
    • 2342442115 scopus 로고    scopus 로고
    • Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays
    • Berchuck, A., Iversen, E. S. and Lancaster, J. M. (2004) Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol, 190:4, pp. 910-925.
    • (2004) Am J Obstet Gynecol , vol.190 , Issue.4 , pp. 910-925
    • Berchuck, A.1    Iversen, E.S.2    Lancaster, J.M.3
  • 18
    • 0033846756 scopus 로고    scopus 로고
    • Complete cytoreduction: Is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?
    • Naik, R., Nordin, A. and Cross, P. A. (2000) Complete cytoreduction: Is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?. Gynecol Oncol, 78:2, pp. 176-180.
    • (2000) Gynecol Oncol , vol.78 , Issue.2 , pp. 176-180
    • Naik, R.1    Nordin, A.2    Cross, P.A.3
  • 19
    • 0018569942 scopus 로고
    • A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
    • Goldie, J. H. and Coldman, A. J. (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep, 63:11, pp. 1727-1733.
    • (1979) Cancer Treat Rep , vol.63 , Issue.11 , pp. 1727-1733
    • Goldie, J.H.1    Coldman, A.J.2
  • 20
    • 0029050211 scopus 로고
    • A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary
    • Allen, D. G., Heintz, A. P. and Touw, F. W. (1995) A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary. Eur J Gynaecol Oncol, 16:5, pp. 349-356.
    • (1995) Eur J Gynaecol Oncol , vol.16 , Issue.5 , pp. 349-356
    • Allen, D.G.1    Heintz, A.P.2    Touw, F.W.3
  • 21
    • 0036498788 scopus 로고    scopus 로고
    • Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    • Bristow, R. E., Tomacruz, R. S. and Armstrong, D. K. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol, 20:5, pp. 1248-1259.
    • (2002) J Clin Oncol , vol.20 , Issue.5 , pp. 1248-1259
    • Bristow, R.E.1    Tomacruz, R.S.2    Armstrong, D.K.3
  • 22
    • 0024496836 scopus 로고
    • Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer
    • Lawton, F. G., Redman, C. W. and Luesley, D. M. (1989) Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer. Obstet Gynecol, 73:1, pp. 61-65.
    • (1989) Obstet Gynecol , vol.73 , Issue.1 , pp. 61-65
    • Lawton, F.G.1    Redman, C.W.2    Luesley, D.M.3
  • 23
    • 0032926077 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
    • Schwartz, P. E., Rutherford, T. J. and Chambers, J. T. (1999) Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival. Gynecol Oncol. 72:1, pp. 93-99.
    • (1999) Gynecol Oncol. , vol.72 , Issue.1 , pp. 93-99
    • Schwartz, P.E.1    Rutherford, T.J.2    Chambers, J.T.3
  • 24
    • 0035876163 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for unresectable ovarian carcinoma: A French multicenter study
    • Ansquer, Y., Leblanc, E. and Clough, K. (2001) Neoadjuvant chemotherapy for unresectable ovarian carcinoma: A French multicenter study. Cancer, 91:12, pp. 2329-2334.
    • (2001) Cancer , vol.91 , Issue.12 , pp. 2329-2334
    • Ansquer, Y.1    Leblanc, E.2    Clough, K.3
  • 25
    • 27444432441 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma
    • Hegazy, M. A., El-Shafei, M. A. and Setit, A. E. (2005) Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma. World J Surg Oncol, 3:1, p. 57.
    • (2005) World J Surg Oncol , vol.3 , Issue.1 , pp. 57
    • Hegazy, M.A.1    El-Shafei, M.A.2    Setit, A.E.3
  • 26
    • 0020438372 scopus 로고
    • Debulking surgery: Does it increase the quality of survival?
    • Blythe, J. G. and Wahl, T. P. (1982) Debulking surgery: Does it increase the quality of survival?. Gynecol Oncol, 14:3, pp. 396-408.
    • (1982) Gynecol Oncol , vol.14 , Issue.3 , pp. 396-408
    • Blythe, J.G.1    Wahl, T.P.2
  • 27
    • 0037227417 scopus 로고    scopus 로고
    • Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: A prospective longitudinal study
    • Chan, Y. M., Ng, T. Y. and Ngan, H. Y. (2003) Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: A prospective longitudinal study. Gynecol Oncol, 88:1, pp. 9-16.
    • (2003) Gynecol Oncol , vol.88 , Issue.1 , pp. 9-16
    • Chan, Y.M.1    Ng, T.Y.2    Ngan, H.Y.3
  • 28
    • 0028237380 scopus 로고
    • The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
    • Hoskins, W. J., McGuire, W. P. and Brady, M. F. (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol, 170:4, pp. 974-979.
    • (1994) Am J Obstet Gynecol , vol.170 , Issue.4 , pp. 974-979
    • Hoskins, W.J.1    McGuire, W.P.2    Brady, M.F.3
  • 29
    • 0023579941 scopus 로고
    • Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma
    • Neijt, J. P., Huinink, W W ten Bokkel and van der Burg, M. E. (1987) Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma. J Clin Oncol, 5:8, pp. 1157-1168.
    • (1987) J Clin Oncol , vol.5 , Issue.8 , pp. 1157-1168
    • Neijt, J.P.1    Huinink, W.W.2    ten Bokkel van der Burg, M.E.3
  • 30
    • 0028661219 scopus 로고
    • Epithelial ovarian carcinoma: Principles of primary surgery
    • Hoskins, W. J. (1994) Epithelial ovarian carcinoma: Principles of primary surgery. Gynecol Oncol, 55:3, pp. S91-S96.
    • (1994) Gynecol Oncol , vol.55 , Issue.3
    • Hoskins, W.J.1
  • 31
    • 0034823377 scopus 로고    scopus 로고
    • Identification of prognostic factors in advanced epithelial ovarian carcinoma
    • Chi, D. S., Liao, J. B. and Leon, L. F. (2001) Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol, 82:3, pp. 532-537.
    • (2001) Gynecol Oncol , vol.82 , Issue.3 , pp. 532-537
    • Chi, D.S.1    Liao, J.B.2    Leon, L.F.3
  • 32
    • 0034111537 scopus 로고    scopus 로고
    • The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma
    • Chi, D. S., Venkatraman, E. S. and Masson, V. (2000) The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol, 77:2, pp. 227-231.
    • (2000) Gynecol Oncol , vol.77 , Issue.2 , pp. 227-231
    • Chi, D.S.1    Venkatraman, E.S.2    Masson, V.3
  • 33
    • 0035889879 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma
    • Kuhn, W., Rutke, S. and Spathe, K. (2001) Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer, 92:10, pp. 2585-2591.
    • (2001) Cancer , vol.92 , Issue.10 , pp. 2585-2591
    • Kuhn, W.1    Rutke, S.2    Spathe, K.3
  • 34
    • 0027394686 scopus 로고
    • Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma
    • Nelson, B. E., Rosenfield, A. T. and Schwartz, P. E. (1993) Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol, 11:1, pp. 166-172.
    • (1993) J Clin Oncol , vol.11 , Issue.1 , pp. 166-172
    • Nelson, B.E.1    Rosenfield, A.T.2    Schwartz, P.E.3
  • 35
    • 0029112083 scopus 로고
    • Ovarian carcinoma: Value of CT in predicting success of debulking surgery
    • Meyer, J. I., Kennedy, A. W. and Friedman, R. (1995) Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR Am J Roentgenol, 165:4, pp. 875-878.
    • (1995) AJR Am J Roentgenol , vol.165 , Issue.4 , pp. 875-878
    • Meyer, J.I.1    Kennedy, A.W.2    Friedman, R.3
  • 36
    • 0034307229 scopus 로고    scopus 로고
    • A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
    • Bristow, R. E., Duska, L. R. and Lambrou, N. C. (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer, 89:7, pp. 1532-1540.
    • (2000) Cancer , vol.89 , Issue.7 , pp. 1532-1540
    • Bristow, R.E.1    Duska, L.R.2    Lambrou, N.C.3
  • 37
    • 12344325535 scopus 로고    scopus 로고
    • Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer
    • Qayyum, A., Coakley, F. V. and Westphalen, A. C. (2005) Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol, 96:2, pp. 301-306.
    • (2005) Gynecol Oncol , vol.96 , Issue.2 , pp. 301-306
    • Qayyum, A.1    Coakley, F.V.2    Westphalen, A.C.3
  • 38
    • 0032422162 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
    • Vergote, I., De Wever, I. and Tjalma, W. (1998) Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients. Gynecol Oncol, 71:3, pp. 431-436.
    • (1998) Gynecol Oncol , vol.71 , Issue.3 , pp. 431-436
    • Vergote, I.1    De Wever, I.2    Tjalma, W.3
  • 39
    • 0032852036 scopus 로고    scopus 로고
    • Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced?
    • van Dam, P. A., DeCloedt, J. and Tjalma, W. A. (1999) Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced?. Am J Obstet Gynecol, 181:3, pp. 536-541.
    • (1999) Am J Obstet Gynecol , vol.181 , Issue.3 , pp. 536-541
    • van Dam, P.A.1    DeCloedt, J.2    Tjalma, W.A.3
  • 40
    • 0038162281 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
    • Mazzeo, F., Berliere, M. and Kerger, J. (2003) Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecol Oncol, 90:1, pp. 163-169.
    • (2003) Gynecol Oncol , vol.90 , Issue.1 , pp. 163-169
    • Mazzeo, F.1    Berliere, M.2    Kerger, J.3
  • 41
    • 15444369315 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy in advanced ovarian cancer: A case-control study
    • Loizzi, V., Cormio, G. and Resta, L. (2005) Neoadjuvant chemotherapy in advanced ovarian cancer: A case-control study. Int J Gynecol Cancer, 15:2, pp. 217-223.
    • (2005) Int J Gynecol Cancer , vol.15 , Issue.2 , pp. 217-223
    • Loizzi, V.1    Cormio, G.2    Resta, L.3
  • 42
    • 0028952438 scopus 로고
    • The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer
    • van der Burg, M. E., van Lent, M. and Buyse, M. (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med, 332:10, pp. 629-634.
    • (1995) N Engl J Med , vol.332 , Issue.10 , pp. 629-634
    • van der Burg, M.E.1    van Lent, M.2    Buyse, M.3
  • 43
    • 19744365355 scopus 로고    scopus 로고
    • Secondary surgical cytoreduction for advanced ovarian carcinoma
    • Rose, P. G., Nerenstone, S. and Brady, M. F. (2004) Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med, 351:24, pp. 2489-2497.
    • (2004) N Engl J Med , vol.351 , Issue.24 , pp. 2489-2497
    • Rose, P.G.1    Nerenstone, S.2    Brady, M.F.3
  • 44
    • 0022722682 scopus 로고
    • The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study
    • Piver, M. S. and Baker, T. (1986) The potential for optimal (less than or equal to 2cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study. Gynecol Oncol, 24:1, pp. 1-8.
    • (1986) Gynecol Oncol , vol.24 , Issue.1 , pp. 1-8
    • Piver, M.S.1    Baker, T.2
  • 45
    • 0034796033 scopus 로고    scopus 로고
    • Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator
    • Bristow, R. E. and Montz, F. J. (2001) Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Gynecol Oncol, 83:1, pp. 39-48.
    • (2001) Gynecol Oncol , vol.83 , Issue.1 , pp. 39-48
    • Bristow, R.E.1    Montz, F.J.2
  • 46
    • 4444330066 scopus 로고    scopus 로고
    • Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach
    • Chi, D. S., Franklin, C. C. and Levine, D. A. (2004) Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach. Gynecol Oncol, 94:3, pp. 650-654.
    • (2004) Gynecol Oncol , vol.94 , Issue.3 , pp. 650-654
    • Chi, D.S.1    Franklin, C.C.2    Levine, D.A.3
  • 47
    • 4444365590 scopus 로고    scopus 로고
    • Diaphragm resection for ovarian cancer: Technique and short-term complications
    • Cliby, W., Dowdy, S. and Feitoza, S. S. (2004) Diaphragm resection for ovarian cancer: Technique and short-term complications. Gynecol Oncol, 94:3, pp. 655-660.
    • (2004) Gynecol Oncol , vol.94 , Issue.3 , pp. 655-660
    • Cliby, W.1    Dowdy, S.2    Feitoza, S.S.3
  • 48
    • 34548585925 scopus 로고    scopus 로고
    • Cytoreductive surgery in advanced ovarian cancer with or without neoadjuvant chemotherapy
    • Abstracts presented for the 30th Annual Meeting of the Society of Gynecologic Oncologists
    • Surwit, E. and Childers, J. (1999) Cytoreductive surgery in advanced ovarian cancer with or without neoadjuvant chemotherapy. Abstracts presented for the 30th Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol, 72, p. 468.
    • (1999) Gynecol Oncol , vol.72 , pp. 468
    • Surwit, E.1    Childers, J.2
  • 49
    • 0036436430 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: A retrospective case-control study
    • Vrscaj, M. U. and Rakar, S. (2002) Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: A retrospective case-control study. Eur J Gynaecol Oncol, 23:5, pp. 405-410.
    • (2002) Eur J Gynaecol Oncol , vol.23 , Issue.5 , pp. 405-410
    • Vrscaj, M.U.1    Rakar, S.2
  • 50
    • 0030054309 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    • McGuire, W. P., Hoskins, W. J. and Brady, M. F. (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med, 334:1, pp. 1-6.
    • (1996) N Engl J Med , vol.334 , Issue.1 , pp. 1-6
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3
  • 51
    • 28944445036 scopus 로고    scopus 로고
    • Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer
    • Faught, W. and Hopkins, L. (2005) Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer. Int J Gynecol Cancer, 15, pp. 770-775.
    • (2005) Int J Gynecol Cancer , vol.15 , pp. 770-775
    • Faught, W.1    Hopkins, L.2
  • 52
    • 0041622805 scopus 로고    scopus 로고
    • Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study
    • Eisenkop, S. M., Spirtos, N. M. and Friedman, R. L. (2003) Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study. Gynecol Oncol, 90:2, pp. 390-396.
    • (2003) Gynecol Oncol , vol.90 , Issue.2 , pp. 390-396
    • Eisenkop, S.M.1    Spirtos, N.M.2    Friedman, R.L.3
  • 53
    • 33750145025 scopus 로고    scopus 로고
    • What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    • Chi, D. S., Eisenhauer, E. L. and Lang, J. (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecol Oncol
    • (2006) Gynecol Oncol
    • Chi, D.S.1    Eisenhauer, E.L.2    Lang, J.3
  • 54
    • 0031033211 scopus 로고    scopus 로고
    • Stage IV ovarian cancer: Impact of surgical debulking
    • Curtin, J. P., Malik, R. and Venkatraman, E. S. (1997) Stage IV ovarian cancer: Impact of surgical debulking. Gynecol Oncol, 64:1, pp. 9-12.
    • (1997) Gynecol Oncol , vol.64 , Issue.1 , pp. 9-12
    • Curtin, J.P.1    Malik, R.2    Venkatraman, E.S.3
  • 55
    • 0032980903 scopus 로고    scopus 로고
    • Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer
    • Bristow, R. E., Montz, F. J. and Lagasse, L. D. (1999) Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol, 72:3, pp. 278-287.
    • (1999) Gynecol Oncol , vol.72 , Issue.3 , pp. 278-287
    • Bristow, R.E.1    Montz, F.J.2    Lagasse, L.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.